Modulators of ATP-binding cassette transporters
The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
1. A compound of formula V-B-5:
wherein:
ring A 2 is a phenyl or a 5-6 membered heteroaryl ring, wherein ring A 2 and the phenyl ring fused thereto together have up 4 substituents independently selected from WR W ; and
W is a bond or is an optionally substituted C 1 -C 6 alkylidene chain wherein up to two methylene units of W are optionally and independently replaced by —CO—, —CS—, —COCO—, —CONR′—, —CONR′NR′—, —CO 2 —, —OCO—, —NR′CO 2 —, —O—, —NR′CONR′—, —OCONR′—, —NR′NR′, —NR′NR′CO—, —NR′CO—, —S—, —SO, —SO 2 —, —NR′—, —SO 2 NR′—, NR′SO 2 —, —NR′SO 2 NR′—;
R W is independently R′, halo, NO 2 , CN, CF 3 , or OCF 3 ;
X is a bond or is an optionally substituted C 1 -C 6 alkylidene chain wherein up to two methylene units of X are optionally and independently replaced by —CO—, —CS—, —COCO—,—CONR′—, —CONR′NR′—, —CO 2 —, —OCO—, —NR′CO 2 —, —O—, —NR′CONR′—, —OCONR′—, —NR′NR′, —NR′NR′CO—, —NR′CO—, —S—, —SO, —SO 2 —,—NR′—, —SO 2 NR′—, NR′SO 2 —, or —NR′SO 2 NR′—;
R X is independently R′, halo, NO 2 , CN, CF 3 , or OCF 3 ;
R′ is independently selected from hydrogen or an optionally substituted group selected from a C 1 -C 8 aliphatic group a 3-8-membered saturated, partially unsaturated, or fully unsaturated monocyclic ring having 0-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or an 8-12 membered saturated, partially unsaturated, or fully unsaturated bicyclic ring system having 0-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur; or two occurrences of R′ are taken together with the atom(s) to which they are bound to form an optionally substituted 3-12 membered saturated, partially unsaturated, or fully unsaturated monocyclic or bicyclic ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; and
m is 0-4.
2. The compound according to claim 1 , wherein ring A 2 is selected from:
wherein said ring is optionally substituted.
3. The compound according to claim 1 , wherein said compound has formula V-B-5-a:
wherein:
G 4 is hydrogen, halo, CN, CF 3 , CHF 2 , CH 2 F, optionally substituted C1-C6 aliphatic, aryl-C1-C6 alkyl, or a phenyl, wherein G 4 is optionally substituted with up to 4 WR W substituents; wherein up to two methylene units of said C1-C6 aliphatic or C1-C6 alkyl is optionally replaced with —CO—, —CONR′—, —CO 2 —, —OCO—, —NR′CO 2 —, —O—, —NR′CONR′—, —OCONR′—, —NR′CO—, —S—, —NR′—, —SO 2 NR′—, NR′SO 2 —, or —NR′SO 2 NR′—;
G 5 is hydrogen or an optionally substituted C1-C6 aliphatic;
wherein said indole ring system is further optionally substituted with up to 3 substituents independently selected from WR W .
4. The compound according to claim 3 , wherein G 4 is hydrogen, and G 5 is C1-C6 aliphatic, wherein said aliphatic is optionally substituted with C1-C6 alkyl, halo, cyano, or CF 3 , and wherein up to two methylene units of said C1-C6 aliphatic or C1-C6 alkyl is optionally replaced with —CO—, —CONR′—, —CO 2 —, —OCO—, —NR′CO 2 —, —O—, —NR′CONR′—, —OCONR′—, —NR′CO—, —S—, —NR′—, —SO 2 NR′—, NR′SO 2 —, or —NR′SO 2 NR′—.
5. The compound according to claim 3 , wherein G 4 is hydrogen, and G 5 is cyano, methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, t-butyl, cyanomethyl, methoxyethyl, CH 2 C(O)OMe, (CH 2 ) 2 —NHC(O)O-tert-But, or cyclopentyl.
6. The compound according to claim 3 , wherein G 5 is hydrogen, and G 4 is halo, C1-C6 aliphatic or phenyl, wherein said aliphatic or phenyl is optionally substituted with C1-C6 alkyl, halo, cyano, or CF 3 , wherein up to two methylene units of said C1-C6 aliphatic or C1-C6 alkyl is optionally replaced with —CO—, —CONR′—, —CO 2 —, —OCO—, —NR′CO 2 —, —O—, —NR′CONR′—, —OCONR′—, —NR′CO—, —S—, —NR′—, —SO 2 NR′—, NR′SO 2 —, or —NR′SO 2 NR′—.
7. The compound according to claim 3 , wherein G 5 is hydrogen, and G 4 is halo, ethoxycarbonyl, t-butyl, 2-methoxyphenyl, 2-ethoxyphenyl, (4-C(O)NH(CH 2 ) 2 —NMe 2 )-phenyl, 2-methoxy-4-chloro-phenyl, pyridine-3-yl, 4-isopropylphenyl, 2,6-dimethoxyphenyl, sec-butylaminocarbonyl, ethyl, t-butyl, or piperidin-1-ylcarbonyl.
8. A compound selected from:
Cmpd
No.
Name
1
N-[5-(5-chloro-2-methoxy-phenyl)-1H-indol-6-yl]-4-oxo-1H-quinoline-3-carboxamide
22
4-Oxo-1,4-dihydro-quinoline-3-carboxylic acid N-(1′,2′-dihydrospiro[cyclopropane-1,3′-
[3H]indol]-6′-yl)-amide
27
N-[1-[2-[methyl-(2-methylaminoacetyl)-amino]acetyl]-1H-indol-6-yl]-4-oxo-1H-
quinoline-3-carboxamide
32
N-(5-chloro-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide
33
N-(1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide
37
N-(1H-indol-7-yl)-4-oxo-1H-quinoline-3-carboxamide
44
N-(2-methylbenzothiazol-5-yl)-4-oxo-1H-quinoline-3-carboxamide
51
6-[(4-methyl-1-piperidyl)sulfonyl]-4-oxo-N-(5-tert-butyl-1H-indol-6-yl)-1H-quinoline-
3-carboxamide
54
4-oxo-N-(8-thia-7,9-diazabicyclo[4.3.0]nona-2,4,6,9-tetraen-5-yl)-1H-quinoline-3-
carboxamide
64
4-oxo-N-(2-oxo-1,3-dihydrobenzoimidazol-5-yl)-1H-quinoline-3-carboxamide
65
4-oxo-N-[5-(3-pyridyl)-1H-indol-6-yl]-1H-quinoline-3-carboxamide
66
N-(2,2-difluorobenzo[1,3]dioxol-5-yl)-4-oxo-1H-quinoline-3-carboxamide
67
6-ethyl-4-hydroxy-N-(1H-indol-6-yl)quinoline-3-carboxamide
73
4-oxo-N-(2-phenyl-3H-benzoimidazol-5-yl)-1H-quinoline-3-carboxamide
77
N-(5-fluoro-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide
96
N-[3-(cyanomethyl)-1H-indol-6-yl]-4-oxo-1H-quinoline-3-carboxamide
100
N-(1H-indol-4-yl)-4-oxo-1H-quinoline-3-carboxamide
104
N-(2-methyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide
105
1,4-dihydro-N-(3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-4-oxoquinoline-3-
carboxamide
107
7-[(4-oxo-1H-quinolin-3-yl)carbonylamino]-1,2,3,4-tetrahydroisoquinoline-2-carboxylic
acid tert-butyl ester
108
4,4-dimethyl-7-[(4-oxo-1H-quinoline-3-yl)carbonylamino]-1,2,3,4-tetrahydroquinoline-
1-carboxylic acid tert-butyl ester
112
6-ethoxy-4-hydroxy-N-(1H-indol-6-yl)quinoline-3-carboxamide
113
N-(3-methyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide
116
5-hydroxy-N-(1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide
124
6-fluoro-4-oxo-N-(5-tert-butyl-1H-indol-6-yl)-1H-quinoline-3-carboxamide
130
4-hydroxy-N-(1H-indol-6-yl)-5,7-bis(trifluoromethyl)quinoline-3-carboxamide
145
6-[(4-oxo-1H-quinolin-3-yl)carbonylamino]-1H-indole-4-carboxylic acid ethyl ester
146
4-oxo-N-(1,7,9-triazabicyclo[4.3.0]nona-2,4,6,8-tetraen-5-yl)-1H-quinoline-3-
carboxamide
148
4-oxo-N-[5-(1-piperidylcarbonyl)-1H-indol-6-yl]-1H-quinoline-3-carboxamide
152
4-oxo-N-(2-oxo-3H-benzooxazol-6-yl)-1H-quinoline-3-carboxamide
158
4-oxo-N-(5-phenyl-1H-indol-6-yl)-1H-quinoline-3-carboxamide
169
N-(1-methyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide
175
4-Oxo-1,4-dihydro-quinoline-3-carboxylic acid N-(1′-Acetyl-1′,2′-
dihydrospiro[cyclopropane-1,3′-3H-indol]-6′-yl)-amide
183
7-[(4-oxo-1H-quinolin-3-yl)carbonylamino]-1,2,3,4-tetrahydroquinoline-1-carboxylic
acid tert-butyl ester
184
N-(1H-indol-6-yl)-4-oxo-2-(trifluoromethyl)-1H-quinoline-3-carboxamide
186
N-(3-cyclopentyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide
187
N-(1-acetyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide
188
6-[(4-oxo-1H-quinolin-3-yl)carbonylamino]-1H-indole-5-carboxylic acid ethyl ester
191
4-oxo-N-(5-quinolyl)-1H-quinoline-3-carboxamide
203
N-(1-benzyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide
204
N-(4,4-dimethylchroman-7-yl)-4-oxo-1H-quinoline-3-carboxamide
207
2-[6-[(4-oxo-1H-quinolin-3-yl)carbonylamino]-1H-indol-3-yl]acetic acid ethyl ester
216
N-(3H-benzoimidazol-2-yl)-4-oxo-1H-quinoline-3-carboxamide
217
N-(1H-indazol-5-yl)-4-oxo-1H-quinoline-3-carboxamide
230
N-(2-methyl-1H-indol-5-yl)-4-oxo-1H-quinoline-3-carboxamide
233
N-(1-acetylindolin-6-yl)-4-oxo-1H-quinoline-3-carboxamide
234
4-oxo-N-[5-(trifluoromethyl)-1H-indol-6-yl]-1H-quinoline-3-carboxamide
237
N-[5-(2-methoxyphenyl)-1H-indol-6-yl]-4-oxo-1H-quinoline-3-carboxamide
238
7′-[(4-oxo-1H-quinolin-3-ylcarbonyl)amino]-spiro[piperidine-4,4′(1′H)-quinoline], 2′,3′-
dihydro-carboxylic acid tert-butyl ester
241
4-oxo-N-(8-quinolyl)-1H-quinoline-3-carboxamide
244
4-oxo-N-(6,7,8,9-tetrahydro-5H-carbazol-2-yl)-1H-quinoline-3-carboxamide
254
6-fluoro-N-(5-fluoro-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide
256
N-(1H-benzotriazol-5-yl)-4-oxo-1H-quinoline-3-carboxamide
258
N-indolin-6-yl-4-oxo-1H-quinoline-3-carboxamide
259
4-oxo-N-(3-sec-butyl-1H-indol-6-yl)-1H-quinoline-3-carboxamide
262
1,4-dihydro-N-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]thiazin-6-yl)-4-oxoquinoline-3-
carboxamide
270
N-(2-cyano-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide
274
4-oxo-6-pyrrolidin-1-ylsulfonyl-N-(5-tert-butyl-1H-indol-6-yl)-1H-quinoline-3-
carboxamide
280
4-oxo-N-(6-quinolyl)-1H-quinoline-3-carboxamide
284
N-(1H-indazol-6-yl)-4-oxo-1H-quinoline-3-carboxamide
294
N-(1H-indol-5-yl)-4-oxo-1H-quinoline-3-carboxamide
299
4-oxo-N-(1,2,3,4-tetrahydroquinolin-7-yl)-1H-quinoline-3-carboxamide
300
N-(4,4-dimethyl-1,2,3,4-tetrahydroquinolin-7-yl)-4-oxo-1H-quinoline-3-carboxamide
303
N-(2-acetyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-4-oxo-1H-quinoline-3-carboxamide
320
4-oxo-N-(2-tert-butyl-1H-indol-6-yl)-1H-quinoline-3-carboxamide
327
N-[5-(2-ethoxyphenyl)-1H-indol-6-yl]-4-oxo-1H-quinoline-3-carboxamide
329
N-[2-(o-tolyl)benzooxazol-5-yl]-4-oxo-1H-quinoline-3-carboxamide
334
7′-[(4-oxo-1H-quinolin-3-ylcarbonyl)amino]-spiro[piperidine-4,4′(1′H)-1-acetyl-
quinoline], 2′,3′-dihydro-carboxylic acid tert-butyl ester
338
N-(3-methyl-1H-indol-4-yl)-4-oxo-1H-quinoline-3-carboxamide
339
N-(3-cyano-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide
342
N-[5-(4-isopropylphenyl)-1H-indol-6-yl]-4-oxo-1H-quinoline-3-carboxamide
343
N-[5-(isobutylcarbamoyl)-1H-indol-6-yl]-4-oxo-1H-quinoline-3-carboxamide
345
6-fluoro-4-hydroxy-N-(1H-indol-6-yl)quinoline-3-carboxamide
347
N-[5-[4-(2-dimethylaminoethylcarbamoyl)phenyl]-1H-indol-6-yl]-4-oxo-1H-quinoline-
3-carboxamide
351
N-(5-ethyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide
352
2-[6-[(4-oxo-1H-quinolin-3-yl)carbonylamino]-1H-indol-3-yl]ethylaminoformic acid
tert-butyl ester
357
N-(3-isopropyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide
358
6-chloro-4-hydroxy-N-(1H-indol-6-yl)quinoline-3-carboxamide
364
N-(2-methyl-8-quinolyl)-4-oxo-1H-quinoline-3-carboxamide
374
4-hydroxy-N-(1H-indol-6-yl)-2-methylsulfanyl-quinoline-3-carboxamide
376
4-oxo-N-(2-phenylbenzooxazol-5-yl)-1H-quinoline-3-carboxamide
377
6,8-difluoro-4-hydroxy-N-(1H-indol-6-yl)quinoline-3-carboxamide
381
4-oxo-N-(5-tert-butyl-1H-indol-6-yl)-1H-quinoline-3-carboxamide
383
N-(3-ethyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide
386
N-(3,3-dimethylindolin-6-yl)-4-oxo-1H-quinoline-3-carboxamide
404
N-[5-(2,6-dimethoxyphenyl)-1H-indol-6-yl]-4-oxo-1H-quinoline-3-carboxamide
406
6-[(4-fluorophenyl)-methyl-sulfamoyl]-4-oxo-N-(5-tert-butyl-1H-indol-6-yl)-1H-
quinoline-3-carboxamide
412
6-[(4-oxo-1H-quinolin-3-yl)carbonylamino]-1H-indole-7-carboxylic acid ethyl ester
414
N-(3H-benzoimidazol-5-yl)-4-oxo-1H-quinoline-3-carboxamide
423
N-[3-(2-ethoxyethyl)-1H-indol-6-yl]-4-oxo-1H-quinoline-3-carboxamide
427
5-[(4-oxo-1H-quinolin-3-yl)carbonylamino]-1,2,3,4-tetrahydroisoquinoline-2-carboxylic
acid tert-butyl ester
437
N-benzo[1,3]dioxol-5-yl-4-oxo-1H-quinoline-3-carboxamide
443
4-oxo-N-quinoxalin-6-yl-1H-quinoline-3-carboxamide
446
N-(1,1-dioxobenzothiophen-6-yl)-4-oxo-1H-quinoline-3-carboxamide
467
N-(2,3-dihydrobenzofuran-5-yl)-4-oxo-1H-quinoline-3-carboxamide
474
N-(3-methyl-2-oxo-3H-benzooxazol-5-yl)-4-oxo-1H-quinoline-3-carboxamide
478
4-oxo-N-(3-tert-butyl-1H-indol-6-yl)-1H-quinoline-3-carboxamide
479
N-(1H-indol-6-yl)-5-methoxy-4-oxo-1H-quinoline-3-carboxamide.